Risvutatug rezetecan, CAS [[3042849-33-9]]

Catalog Number: MCE-HY-185279
Article Name: Risvutatug rezetecan, CAS [[3042849-33-9]]
Biozol Catalog Number: MCE-HY-185279
Supplier Catalog Number: HY-185279
Alternative Catalog Number: MCE-HY-185279-1MG, MCE-HY-185279-5MG, MCE-HY-185279-10MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: HS-20093, GSK5764227
Risvutatug rezetecan (HS-20093, GSK5764227) is a B7-H3-targeting antibody-drug conjugate (ADC). Risvutatug rezetecan binds to B7-H3 on tumor cells and delivers a topoisomerase I inhibitor payload via a tumor microenvironment-responsive cleavable linker. Risvutatug rezetecan is applicable for the research of extensive-stage small cell lung cancer and non-small cell lung cancer[1].
CAS Number: [3042849-33-9]
Target: Antibody-Drug Conjugates (ADCs),CD276/B7-H3
Application Notes: MCE Product type: ADC Related